Clcl/ll Ullll# MUftl IU W Icily t;l 1 lt;l 1 1 ricocipi
EFS ID:
1768713
Application Number:
09993647
International Application Number:
Confirmation Number:
1010
Title of Invention:
omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
First Named Inventor/Applicant Name:
Bernd Riedl
Customer Number:
23599
Filer:
I. William Millen
Filer Authorized By:
Attorney Docket Number:
BAYER 18A
Receipt Date:
11-MAY-2007
Filing Date:
27-NOV-2001
Time Stamp:
17:32:29
Application Type:
Utility
Payment information:
Submitted with Payment
yes
Payment was successfully received in RAM
$180
RAM confirmation Number
905
Deposit Account
File Listing:
Document Document Description File Name File Size(Bytes) D M . u ! fl . ,. Page ®
Number K v 7 ' Part /.zip (ifappl.)
1
Information Disclosure Statement
InformationDisclosureStatem
no
/|nc\ EilaH
enio-i l -u/ .par
32890
4
Warnings:
Information:
This is not an
USPTO supplied IDS tillable form
Information Disclosure Statement
124006
2
(IDS) Filed
IDS1449FORM-5-11-07.pdf
no
9
Warnings:
Information:
This is not an
USPTO supplied IDS tillable form
3
Foreign Reference
EP0709225B1_TOT.pdf
2373710
no
72
Warnings:
Information:
4
Foreign Reference
WO0056331_TOT.pdf
3383955
no
89
Warnings:
Information:
5
Foreign Reference
WO02062763_TOT.pdf
5240693
no
125
Warnings:
Information:
6
Foreign Reference
WO02083628_TOT.pdf
5812707
no
155
Warnings:
Information:
7
Foreign Reference
WO02085857_TOT.pdf
2905347
no
65
Warnings:
Information:
8
Foreign Reference
WO02085859_TOT.pdf
4380241
no
97
Warnings:
Information:
9
Foreign Reference
WO03099771_TOT.pdf
7914752
no
170
Warnings:
Information:
10
Foreign Reference
WO9709973_TOT.pdf
10826132
no
318
Warnings:
Information:
11
Foreign Reference
W09932111-TOT.pdf
5097241
no
126
Warnings:
Information:
12
NPL Documents
AdjeietalAphaselstudy.pdf
69532
no
1
Warnings:
Information:
13
NPL Documents
AhmadetalKinaselnhibition.p
df
590309
no
5
Warnings:
Information:
14
NPL Documents
AuclairetalBAY43-9006.pdf
59931
no
1
Warnings:
Information:
15
NPL Documents
Bankstonetal.pdf
365909
no
5
Warnings:
Information:
16
NPL Documents
Blancop38.pdf
812373
no
9
Warnings:
Information:
17
NPL Documents
Bollagetal.pdf
525209
no
6
Warnings:
Information:
18
NPL Documents
CampbelletallncreasingCom
plexity.pdf
2424350
no
19
Warnings:
Information:
19
NPL Documents
ChangetalBay43-9006sorafe
nib.pdf
73262
no
1
Warnings:
Information:
20
NPL Documents
CarterExperimentalMolecular
TherapeuticsProceedingsoft
heAmericanAssociationforCa
ncerResearch.pdf
1 73325
no
1
Warnings:
Information:
21
NPL Documents
ClarketalSafetyandPharmac
okinetics.pdf
1034920
no
9
Warnings:
Information:
22
NPL Documents
Cunninghametal.pdf
529224
no
7
Warnings:
Information:
23
NPL Documents
DansonetallmprovingOutcom
es.pdf
859338
no
11
Warnings:
Information:
24
NPL Documents
DeGrendeleH.pdf
222928
no
3
Warnings:
Information:
25
NPL Documents
DumasDiscoverofanewclass
p38.pdf
269973
no
4
Warnings:
Information:
26
NPL Documents
Dumasprotienkinaseinhibitor.
pdf
750454
no
10
Warnings:
Information:
27
NPL Documents
DumasRecentdevelopments.
par
1279668
no
17
Warnings:
Information:
28
NPL Documents
DumasSynthesisandparmac
ological.pdf
337191
no
4
Warnings:
Information:
29
NPL Documents
EisenetalPhaseltrialofBAY.p
df
66103
no
1
Warnings:
Information:
30
NPL Documents
Eisenhaueretallmpactofnewn
on-cytotoxics.pdf
512335
no
5
Warnings:
Information:
31
NPL Documents
EscudieretalRandomizedPha
selll.pdf
71404
no
1
Warnings:
Information:
32
NPL Documents
factsandcomparison.pdf
662046
no
4
Warnings:
Information:
33
NPL Documents
Garcia-LopezetalNewroutes.
pdf
42766
no
1
Warnings:
Information:
34
NPL Documents
GeigeretalAntitumoractivity.p
df
545816
no
7
Warnings:
Information:
35
NPL Documents
Hanson lnhibitorsofp38kinase
.pdf
49863
no
1
Warnings:
Information:
36
NPL Documents
Hanson Pulmonary-Allergy. p
UT
291872
no
5
Warnings:
Information:
37
NPL Documents
HeimetalAntitumoreffect.pdf
157173
no
2
Warnings:
Information:
38
NPL Documents
Hotteetal.pdf
393065
no
5
Warnings:
Information:
39
NPL Documents
HotteetalBAY43-9006.pdf
393995
no
5
Warnings:
Information:
40
NPL Documents
HubbardOncogenicMutations
.pdf
318340
no
3
Warnings:
Information:
41
NPL Documents
IwadateetallntraarterialACN
U.pdf
96571
no
2
Warnings:
Information:
42
NPL Documents
KempteretalSynthesepotenti
eller.pdf
1396625
no
20
Warnings:
Information:
43
NPL Documents
Khireetal.pdf
262018
no
4
Warnings:
Information:
44
NPL Documents
Kuboetal.pdf
1 73337
no
1
Warnings:
Information:
45
NPL Documents
LeeandMcCubrey.pdf
589793
no
7
Warnings:
Information:
46
NPL Documents
LemoineReference.pdf
936752
no
8
Warnings:
Information:
47
NPL Documents
LowingerDesignandDiscover
y.pdf
627223
no
10
Warnings:
Information:
48
NPL Documents
LowingerDiscoveryofanovel.
pdf
148604
no
1
Warnings:
Information:
49
NPL Documents
LyonsetalDiscoveryofanovel.
pdf
816218
no
8
Warnings:
Information:
50
NPL Documents
Madwedetal.pdf
77971
no
1
Warnings:
Information:
51
NPL Documents
MoellingetalSignalTransducti
on. pdf
845713
no
9
Warnings:
Information:
52
NPL Documents
MooreetalPhaselstudytodete
rmine.pdf
576594
no
7
Warnings:
Information:
53
NPL Documents
Mrossetal.pdf
1 87834
no
2
Warnings:
Information:
54
NPL Documents
MurphyetalBAY43-90006con
trols.pdf
71331
no
1
Warnings:
Information:
55
NPL Documents
Reganetal.pdf
1709151
no
15
Warnings:
Information:
56
NPL Documents
MurtaetalFacileSynthesis.pdf
1 68440
no
2
Warnings:
Information:
57
NPL Documents
NickeletalCarboxylicacid.pdf
415868
no
6
Warnings:
Information:
58
NPL Documents
PankaetalBAY43-9006induc
es.pdf
43543
no
1
Warnings:
Information:
59
NPL Documents
Redmanetal.pdf
269247
no
4
Warnings:
Information:
60
NPL Documents
RavietalActivatedRafl .pdf
723840
no
7
Warnings:
Information:
61
Fee Worksheet (PTO-06)
fee-info. pdf
8194
no
2
Warnings:
Information:
Total Files Size (in bytes)
72119215
This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt
similar to a Post Card, as described in MPEP 503.
New Applications Under 35 U.S.C. 111
If a new application is being filed and the application includes the necessary components for a filing date (see
37 CFR 1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date
shown on this Acknowledgement Receipt will establish the filing date of the application.
National Stage of an International Application under 35 U.S.C. 371
If a timely submission to enter the national stage of an international application is compliant with the conditions
of 35 U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the
application as a national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt,
in due course.
New International Application Filed with the USPTO as a Receiving Office
If a new international application is being filed and the international application includes the necessary
components for an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the
International Application Number and of the International Filing Date (Form PCT/RO/105) will be issued in due
course, subject to prescriptions concerning national security, and the date shown on this Acknowledgement
Receipt will establish the international filing date of the application.